CPMG Inc. Amends Stake in PROCEPT BioRobotics

TL;DR

CPMG Inc. just updated its 13D filing for PROCEPT BioRobotics. Big ownership change incoming?

AI Summary

On May 22, 2024, CPMG Inc. filed an amendment (Amendment No. 6) to its Schedule 13D regarding PROCEPT BioRobotics Corporation. The filing indicates a change in beneficial ownership, with CPMG Inc. now holding a significant stake in the company. The filing was made by John Bateman, authorized to receive notices for CPMG Inc.

Why It Matters

This filing signals a potential shift in the ownership structure or investment strategy of CPMG Inc. concerning PROCEPT BioRobotics, which could influence the company's future direction.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings can indicate significant investor activity, potentially leading to stock price volatility.

Key Players & Entities

• CPMG Inc. (company) — Filing entity
• PROCEPT BioRobotics Corporation (company) — Subject company
• John Bateman (person) — Authorized contact for CPMG Inc.

FAQ

Key Financial Figures

• $0.00001 — ame of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securiti

Filing Documents

• ef20029705_sc13da.htm (SC 13D/A) — 138KB
• 0001140361-24-027211.txt ( ) — 140KB

of the Schedule 13D is hereby amended by adding the following

Item 1 of the Schedule 13D is hereby amended by adding the following: This Amendment No. 6 to Schedule 13D ("Amendment No. 6") is being filed by the undersigned, pursuant to 240.13d-2(a), with respect to the Common Stock, $0.00001 par value per share (the "Shares"), of PROCEPT BioRobotics Corporation (the "Issuer" or the "Company"), whose principal executive offices are located at 150 Baytech Drive, San Jose, California 95134. This Amendment No. 6 amends and supplements the Schedule 13D filed by the Reporting Persons with the U.S. Securities and Exchange Commission (the "SEC") on September 27, 2021, as amended by Amendment No. 1 filed with the SEC on September 8, 2022, Amendment No. 2 filed with the SEC on September 13, 2022, Amendment No. 3 filed with the SEC on November 16, 2022, Amendment No. 4 filed with the SEC on December 7, 2022, and Amendment No. 5 filed with the SEC on May 7, 2024 (collectively, "the Schedule 13D"). Except as specifically provided herein, this Amendment No. 6 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used but not defined in this Amendment No. 6 shall have the meanings given to them in the Schedule 13D. Item 5. Interest in Securities of the Issuer

of the Schedule 13D is hereby amended by adding the following

Item 5 of the Schedule 13D is hereby amended by adding the following: (a, b) As of the date hereof, CPMG may be deemed to be the beneficial owner of 958,334 Shares (approximately 1.9% of the total number of Shares outstanding). This amount includes: (i) 711,547 Shares held for the account of WTP; (ii) 180,527 Shares held for the account of Mallard Fund; and (iii) 66,260 Shares held for the account of Kestrel Fund. CPMG is the general partner and investment manager of each of WTP, Mallard Fund and Kestrel Fund. As of the date hereof, Mr. McGaughy may be deemed to be the beneficial owner of 1,770,407 Shares (approximately 3.4% of the total number of Shares outstanding). This amount includes: (i) 958,334 Shares beneficially owned by CPMG; (ii) 806,259 Shares held by Lagos Trust, of which Mr. McGaughy is trustee and shares voting and dispositive power with his spouse; and (iii) 5,814 Shares held directly by Mr. McGaughy. As of the date hereof, Mr. Desai may be deemed to be the beneficial owner of 1,455,618 Shares (approximately 2.8% of the total number of Shares outstanding). This amount includes: (i) 958,334 Shares beneficially owned by CPMG; (ii) 57,807 Shares held directly by Mr. Desai; (iii) 367,035 Shares held by The 2:22 DNA Trust; and (iv) 72,442 Shares that are obtainable upon exercise of options granted to Mr. Desai. As of the date hereof, WTP may be deemed the beneficial owner of 711,547 Shares (approximately 1.4% of the total number of Shares outstanding) held for its account. Each of the Reporting Persons exercises shared voting power and shared dispositive power over the 711,547 Shares held for the account of WTP. CPMG, Mr. McGaughy and Mr. Desai exercise shared voting power and shared dispositive power over the 180,527 Shares held for the account of Mallard Fund and the 66,260 Shares held for the account of Kestrel Fund. Mr. McGaughy and his spouse exercise shared voting power and shared dispositive power over the 806,259 Shares held by Lagos Trust. M

View Full Filing

View this SC 13D/A filing on SEC EDGAR